We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$245M
AUM Growth
+$54.9M
Cap. Flow
+$50.7M
Cap. Flow %
20.67%
Top 10 Hldgs %
5.1%
Holding
864
New
386
Increased
90
Reduced
68
Closed
320

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$1.38M
2
DVN icon
Devon Energy
DVN
+$1.34M
3
DIS icon
Walt Disney
DIS
+$1.23M
4
IART icon
Integra LifeSciences
IART
+$1.2M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.15M

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$1.02M
2
GILD icon
Gilead Sciences
GILD
+$1.02M
3
UGI icon
UGI
UGI
+$884K
4
AVNS icon
Avanos Medical
AVNS
+$880K
5
GIL icon
Gildan
GIL
+$870K

Sector Composition

Rank Sector Weight
1 Healthcare 13.53%
2 Technology 12.85%
3 Industrials 12.5%
4 Consumer Discretionary 12.47%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHP icon
126
BHP
BHP
$205B
$607K 0.25%
+18,721
New +$647K
COF icon
127
Capital One
COF
$129B
$607K 0.25%
+7,000
New +$624K
CRI icon
128
Carter's
CRI
$1.39B
$602K 0.25%
6,700
+3,700
+123% +$319K
HD icon
129
Home Depot
HD
$335B
$602K 0.25%
+4,100
New +$581K
WEX icon
130
WEX
WEX
$5.68B
$600K 0.24%
+5,800
New +$644K
DHR icon
131
Danaher
DHR
$144B
$599K 0.24%
7,896
+2,594
+49% +$193K
TMO icon
132
Thermo Fisher Scientific
TMO
$196B
$599K 0.24%
+3,900
New +$596K
BCR
133
DELISTED
CR Bard Inc.
BCR
$596K 0.24%
+2,400
New +$579K
ABT icon
134
Abbott
ABT
$176B
$591K 0.24%
+13,300
New +$575K
SNI
135
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$589K 0.24%
+7,521
New +$581K
TX icon
136
Ternium
TX
$8.83B
$588K 0.24%
22,500
+3,400
+18% +$84.5K
HAL icon
137
Halliburton
HAL
$29.4B
$583K 0.24%
+11,853
New +$637K
IFF icon
138
International Flavors & Fragrances
IFF
$19.8B
$580K 0.24%
+4,379
New +$538K
KYNB
139
Kyntra Bio
KYNB
$29.3M
$574K 0.23%
+932
New +$568K
KLIC icon
140
Kulicke & Soffa
KLIC
$5.25B
$573K 0.23%
+28,200
New +$542K
APAM icon
141
Artisan Partners
APAM
$2.71B
$569K 0.23%
+20,600
New +$591K
MASI
142
DELISTED
Masimo
MASI
$569K 0.23%
6,100
-2,800
-31% -$231K
RMD icon
143
ResMed
RMD
$28.2B
$569K 0.23%
7,900
+1,300
+20% +$89.8K
AMAT icon
144
Applied Materials
AMAT
$436B
$568K 0.23%
+14,600
New +$524K
KEYS icon
145
Keysight
KEYS
$54.9B
$563K 0.23%
15,574
+7,074
+83% +$263K
ACOR
146
DELISTED
Acorda Therapeutics
ACOR
$561K 0.23%
+223
New +$642K
FAF icon
147
First American
FAF
$7.42B
$558K 0.23%
14,200
-3,100
-18% -$119K
MPC icon
148
Marathon Petroleum
MPC
$91.7B
$556K 0.23%
11,000
-1,900
-15% -$94.6K
ADTN icon
149
Adtran
ADTN
$956M
$554K 0.23%
26,700
+6,400
+32% +$139K
FRC
150
DELISTED
First Republic Bank
FRC
$553K 0.23%
+5,900
New +$555K
4 5
6
7 8

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q1 2017 Portfolio in Review

As of Q1 2017, Fox Run Management held 864 positions worth $245M, up 29% from $190M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.

Fox Run Management deployed $50.7M of net new capital in Q1 2017, opening 386 new positions and adding to 90 existing holdings. Its largest new stake was Edwards Lifesciences: 44,100 shares worth $1.38M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was UGI, an estimated $884K trimmed.

  • Fox Run Management's largest Q1 2017 buy was Edwards Lifesciences: 44,100 shares worth $1.38M.
  • Fox Run Management added most to Capri Holdings in Q1 2017, an estimated $746K increase.
  • Fox Run Management's biggest Q1 2017 reduction was UGI, cutting an estimated $884K.
  • Fox Run Management fully exited American Tower in Q1 2017, selling an estimated $1.02M.
  • Fox Run Management's ten largest holdings make up 5.1% of its $245M portfolio in Q1 2017.
  • Fox Run Management opened 386 new positions and closed 320 in Q1 2017.
  • Fox Run Management's portfolio value rose 29% quarter-over-quarter to $245M.

Based on Fox Run Management's 13F filing for Q1 2017, filed 17 Apr 2017.